WallStreetZenWallStreetZen

NASDAQ: NEO
Neogenomics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for NEO

Based on 6 analysts offering 12 month price targets for Neogenomics Inc.
Min Forecast
$17.00+22.74%
Avg Forecast
$20.00+44.4%
Max Forecast
$24.00+73.29%

Should I buy or sell NEO stock?

Based on 6 analysts offering ratings for Neogenomics Inc.
Strong Buy
Strong Buy
3 analysts 50%
Buy
2 analysts 33.33%
Hold
1 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NEO stock forecasts and price targets.

NEO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-26
lockedlocked$00.00+00.00%2024-02-22
lockedlocked$00.00+00.00%2024-02-21
lockedlocked$00.00+00.00%2023-12-29
lockedlocked$00.00+00.00%2023-12-29
Morgan Stanley
Bottom 15%
15
HoldMaintains$17.00+22.74%2023-11-08

1 of 1

Forecast return on equity

Is NEO forecast to generate an efficient return?
Company
N/A
Industry
0.02%
Market
20.01%

Forecast return on assets

Is NEO forecast to generate an efficient return on assets?
Company
N/A
Industry
0.02%

NEO revenue forecast

What is NEO's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$654.9M+10.69%
Avg 2 year Forecast
$720.7M+21.82%
Avg 3 year Forecast
$781.8M+32.14%
NEO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NEO revenue growth forecast

How is NEO forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
10.28%
Industry
5.28%
Market
9.45%
NEO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NEO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NEO vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
NEO$13.85$20.00+44.40%Strong Buy
MYGN$18.92$22.00+16.28%Buy
TWST$28.61$42.67+49.13%Strong Buy
GH$16.16$37.50+132.05%Strong Buy
NEOG$12.16$17.00+39.80%Hold
View Top Diagnostic & Research Stocks

Neogenomics Stock Forecast FAQ

Is Neogenomics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: NEO) stock is to Strong Buy NEO stock.

Out of 6 analysts, 3 (50%) are recommending NEO as a Strong Buy, 2 (33.33%) are recommending NEO as a Buy, 1 (16.67%) are recommending NEO as a Hold, 0 (0%) are recommending NEO as a Sell, and 0 (0%) are recommending NEO as a Strong Sell.

If you're new to stock investing, here's how to buy Neogenomics stock.

What is NEO's revenue growth forecast for 2024-2026?

(NASDAQ: NEO) Neogenomics's forecast annual revenue growth rate of 10.28% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.28%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.45%.

Neogenomics's revenue in 2024 is $591,643,000.On average, 6 Wall Street analysts forecast NEO's revenue for 2024 to be $83,569,900,391, with the lowest NEO revenue forecast at $83,074,135,389, and the highest NEO revenue forecast at $83,980,166,666. On average, 6 Wall Street analysts forecast NEO's revenue for 2025 to be $91,973,659,509, with the lowest NEO revenue forecast at $91,266,699,893, and the highest NEO revenue forecast at $92,517,278,275.

In 2026, NEO is forecast to generate $99,764,252,390 in revenue, with the lowest revenue forecast at $99,472,025,401 and the highest revenue forecast at $100,056,479,379.

What is NEO's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: NEO) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 0.02%.

What is NEO's Price Target?

According to 6 Wall Street analysts that have issued a 1 year NEO price target, the average NEO price target is $20.00, with the highest NEO stock price forecast at $24.00 and the lowest NEO stock price forecast at $17.00.

On average, Wall Street analysts predict that Neogenomics's share price could reach $20.00 by Feb 26, 2025. The average Neogenomics stock price prediction forecasts a potential upside of 44.4% from the current NEO share price of $13.85.

What is NEO's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: NEO) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.